Iron and age-related macular degeneration

Klinika Oczna

Volumn 111, Issue 4-6, 2009, Pages 174-177

  Błasiak, Janusz ^a   Skłodowska, Anna ^b   Ulińska, Magdalena ^b   Szaflik, Jacek P ^b  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Age related macular degeneration; AMD; Celuroplazmin; DNA damage; Ferritin; Iron ions; Oxidative stress; RPE cells; Transferring

Indexed keywords

TRANSFERRIN;

ANIMAL; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; IRON OVERLOAD; METABOLISM; OXIDATIVE STRESS; PIGMENT EPITHELIUM; RETINA; RETINA DEGENERATION; RETINA MACULA DEGENERATION; REVIEW;

ANIMALS; EPITHELIAL CELLS; HOMEOSTASIS; HUMANS; IRON OVERLOAD; MACULAR DEGENERATION; OXIDATIVE STRESS; PIGMENT EPITHELIUM OF EYE; RETINA; RETINAL DEGENERATION; TRANSFERRIN;

EID: 70349260786     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Feret A, Steinweg S, Griffin HC, Glover S: Macular degeneration: types, causes, and possible interventions. Geriatr Nurs 2007, 28, 387-392.
2. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT: Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998, 116, 653-658. (Pubitemid 28414581)
3. Beatty S, Koh H, Phil M, Henson D, Boulton M: The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000, 45, 115-134.
4. Baker E, Morgan EH: Iron transport. In: Brock J, Halliday JH, Pippard MH, Powell LW (Eds.): Iron metabolism in health and disease. Saunders WB, Philadelphia, 1994, 63-95.
5. Hentze MW, Kuhn LC: Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA, 1996, 93, 8175-8182. (Pubitemid 26269529)
6. Levi S, Corsi B, Bosisio M, Invemizzi R, Volz A, Sanford D, Arosio P, Drysdale J: A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 2001, 276, 24437-24440.
7. Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, Rolandi V, Biasiotto G, Drysdale J, Arosio P: Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 2003, 101, 1996-2000. (Pubitemid 36237606)
8. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ: A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000, 5, 299-309. (Pubitemid 30628088)
9. Yefimova MG, Jeanny JC, Keller N, Sergeant C, Guillonneau X, Beaumont C, Courtois Y: Impaired retinal iron homeostasis associated with defective phagocytosis in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 2002, 43, 537-545. (Pubitemid 34113240)
10. Yefimova MG, Jeanny JC, Guillonneau X, Keller N, Nguyen-Legros J, Sergeant C, Guillou F, Courtois Y: Iron, ferritin, transferrin, and transferrin receptor in the adult rat retina. Invest Ophthalmol Vis Sci 2000, 41, 2343-2351. (Pubitemid 30451012)
11. Tripathi RC, Millard CB, Tripathi BJ, Chailertborisuth NS, Neely KA, Ernest JT: Aqueous humor of cat contains fibroblast growth factor and transferrin similar to those in man. Exp Eye Res 1990, 50, 109-112. (Pubitemid 20058629)
12. Hawkins KN: Contribution of plasma proteins to the vitreous of the rat. Curr Eye Res 1986, 5, 655-663. (Pubitemid 17195448)
13. Laicine EM, Haddad A: Transferrin, one of the major vitreous proteins, is produced within the eye. Exp Eye Res 1994, 59, 441-445.
14. Burdo JR, Antonetti DA, Wolpert EB, Connor JR: Mechanisms and regulation of transferrin and iron transport in a model blood-brain barrier system. Neuroscience 2003, 121, 883-890. (Pubitemid 37324587)
15. He X, Hahn P, lacovelli J, Wong R, King C, Bhisitkul R, Massaro-Giordano M, Dunaief JL: Iron homeostasis and toxicity in retinal degeneration. Prog Retinal Eye Res 2007, 26, 649-673. (Pubitemid 47615564)
16. Cheah JH, Kim SF, Hester LD, Clancy KW, Patterson III SE, Papadopoulos V, Snyder SH: NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 2006, 51, 431-440. (Pubitemid 44209322)
17. Aisen P, Enns C, Wessling-Resnick M: Chemistry and biology of eukaryotic iron metabolism. Int J Biochem Cell Biol 2001, 33, 940-959. (Pubitemid 32706687)
18. Linsenmayer TF, Cai CX, Millholland JM, Beazley KE, Fitch JM: Nuclear ferritin in corneal epithelial cells: tissue-specific nuclear transport and protection from UV-damage. Prog Retin Eye Res 2005, 24, 139-159. (Pubitemid 40018222)
19. Osaki S, Johnson DA, Frieden E: The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 1966, 241, 2746-2751.
20. Dunaief JL: Iron induced oxidative damage as a potential factor in age-related macular degeneration. Investigative Ophthalmology & Visual Science 2006, 47, 4660-4664. (Pubitemid 46586359)
21. Hahn P, Milam AH, Dunaief JL: Maculas affected by AMD contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Arch. Ophthalmol 2003, 121, 1099-1105. (Pubitemid 36962162)
22. Hahn P, Ying GS, Beard J, Dunaief JL: Iron levels in human retina: sex difference and increase with age. Neuroreport 2006, 17, 1803-1806. (Pubitemid 44948111)
23. Chowers I, Wong R, Dentchev T, Farkas RH, lacovelli J, Gunatilaka TL, Medeiros NE, Presley JB, Campochiaro PA, Curcio CA, Dunaief JL, Zack DJ: The iron carrier transferrin is upregulated in retinas from patients with agerelated macular degeneration. Invest Ophthalmol Vis Sci 2006, 47, 2135-2140. (Pubitemid 46768298)
24. Hahn P, Qian Y, Dentchev T, Chen L, Beard J, Harris ZL, Dunaief JL: Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci USA, 2004, 101, 13850-13855. (Pubitemid 39298496)
25. Rogers BS, Symons RC, Komeima K, Shen J, Xiao W, Swaim ME, Gong YY, Kachi S, Campochiaro PA: Differential sensitivity of cones to iron-mediated oxidative damage. Invest Ophthalmol Vis Sci 2007, 48, 438-445. (Pubitemid 47251435)
26. AREDS: A randomized, placebo-controlled, clinical trial of high dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001, 119, 1417-1436.
27. Zheng H, Weiner LM, Bar-Am O, Epsztejn S, Cabantchik ZI, Warshawsky A, Youdim MB, Fridkin M: Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases. Bioorg Med Chem 2005, 13, 773-783. (Pubitemid 40093620)
28. Richardson DR: Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions. Ann NY Acad Sci 2004, 1012, 326-341. (Pubitemid 38453535)
29. Leure-du Pree AE, Connor MJ: The effect of deferoxamine, an iron chelator, on the morphology of the retina. Prog Clin Biol Res 987, 247, 517-529.